$0.050000
0.0125.00%
Pre-Market: Oct 9, 6:01 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Bristol-Myers Squibb Company Celegne Contingent Value Rights in recent months.
Browse guidance and forecast on all stocks.